NEW YORK (GenomeWeb News) – Molecular diagnostics firm Xagenic today announced that it has closed a Series B round of financing that brought in $20 million (US$18.8 million) in funding.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.
A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.
A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.
The BabySeq project to study the risks and benefits of sequencing newborns is underway.